Vycor Medical Inc (VYCO): Total Liabilities
$4.92M
As of 2025-12-31
$5.06M
As of 2026-06-30
+9.0%
3-year compound annual growth
+10.6%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.92M | +4.9% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $4.69M | +8.6% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $4.32M | +13.6% | 2025-04-15, Balance as of period end |
| 2022-12-31 | $3.80M | +14.1% | 2024-04-16, Balance as of period end |
| 2021-12-31 | $3.33M | +12.2% | 2023-04-14, Balance as of period end |
| 2020-12-31 | $2.97M | n/a | 2022-04-13, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Vycor Medical Inc (VYCO) | 2025-12-31 | $4.92M | +4.9% |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | $71.64M | +45.6% |
| Femasys Inc (FEMY) | 2025-12-31 | $14.85M | +46.5% |
| QHSLab, Inc. (USAQ) | 2025-12-31 | $546.1K | -77.3% |
| SeaStar Medical Holding Corp (ICU) | 2025-12-31 | $3.74M | -45.3% |
| OSR Health, Inc. (OSRH) | 2025-12-31 | $44.20M | +38.0% |
| PetVivo Holdings, Inc. (PETV) | 2026-03-31 | $1.38M | -73.1% |
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $2.67M | -26.6% |
| Nuo Therapeutics, Inc. (AURX) | 2025-12-31 | $2.80M | +314.7% |
Compare VYCO, NONE., FEMY, USAQ side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗